Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,163Revenue $M45.9Net Margin (%)-57.6Z-Score17.9
Enterprise Value $M984EPS $-0.4Operating Margin %-58.4F-Score4
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-57.6Higher ROA y-yY
Price/Book5.610-y EBITDA Growth Rate %-2.7Quick Ratio9.1Cash flow > EarningsY
Price/Sales24.75-y EBITDA Growth Rate %-4.7Current Ratio9.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-11.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-13.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M69.2ROI % (ttm)-33.3Gross Margin Increase y-yN

Gurus Latest Trades with SGMO

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SGMOJoel Greenblatt 2014-12-31 Buy $9.85 - $16.53
($12.15)
$ 16.8238%New holding, 17441 sh.17,441
SGMOJean-Marie Eveillard 2014-06-30 Add0.01%$11.71 - $17.95
($14.37)
$ 16.8217%Add 34.1%536,380
SGMOJean-Marie Eveillard 2014-03-31 Reduce-0.02%$13.25 - $23.86
($19.12)
$ 16.82-12%Reduce -52.81%400,000
SGMOJean-Marie Eveillard 2013-09-30 Add0.01%$7.92 - $11.28
($9.95)
$ 16.8269%Add 99.73%847,550
SGMOJean-Marie Eveillard 2013-06-30 Add$7.31 - $10.65
($8.72)
$ 16.8293%Add 41.45%424,350
SGMOJean-Marie Eveillard 2013-03-31 Buy 0.01%$6.01 - $10.8
($8.89)
$ 16.8289%New holding, 300000 sh.300,000
SGMOJean-Marie Eveillard 2010-03-31 Sold Out $4.76 - $6.63
($5.63)
$ 16.82199%Sold Out0
SGMOJean-Marie Eveillard 2009-12-31 Buy $5.04 - $8.09
($5.87)
$ 16.82186%New holding, 470 sh.470
SGMOJean-Marie Eveillard 2009-09-30 Sold Out -0.01%$4.26 - $9.03
($6.32)
$ 16.82166%Sold Out0
SGMOJean-Marie Eveillard 2009-06-30 Buy 0.01%$3.51 - $4.98
($4.2)
$ 16.82300%New holding, 260600 sh.260,600
SGMOJean-Marie Eveillard 2009-03-31 Sold Out -0.01%$2.99 - $5.05
($4.1)
$ 16.82310%Sold Out0
SGMOJean-Marie Eveillard 2008-12-31 Buy 0.01%$2.13 - $7.81
($4.6)
$ 16.82266%New holding, 288000 sh.288,000
SGMOJean-Marie Eveillard 2008-06-30 Sold Out $9.07 - $13.37
($11.3)
$ 16.8249%Sold Out0
SGMOJean-Marie Eveillard 2007-12-31 Buy 0.01%$12.81 - $18.5
($15.1)
$ 16.8211%New holding, 50000 sh.50,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SGMO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SGMO Joel Greenblatt 2014-12-3117,4410.030New Buy
SGMO Jean-Marie Eveillard 2014-12-31559,7800.810.02+4.36%
SGMO - CALLJean-Marie Eveillard 2014-12-314,0170.010
Premium Most recent portfolio changes are included for Premium Members only!


SGMO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LANPHIER EDWARD O IIPresident & CEO 2015-02-17Sell25,000$15.695.93view
Ramasastry SairaDirector 2015-02-12Sell10,000$1510.8view
Wolff Henry WardExec VP & CFO 2015-02-10Sell12,000$12.6531.38view
ANDO DALE GVP, Therapeutic Dev. & CMO 2015-02-05Sell15,000$12.9328.54view
RINGO WILLIAM RDirector 2015-02-03Sell2,200$12.730.87view
Gregory Philip DSVP of Research & CSO 2015-02-02Sell15,000$12.8629.24view
LANPHIER EDWARD O IIPresident & CEO 2015-01-16Sell25,000$14.2216.88view
ANDO DALE GVP, Therapeutic Dev. & CMO 2015-01-05Sell15,000$15.199.41view
LARSON JOHN WILLIAMDirector 2015-01-05Sell15,000$15.110.07view
RINGO WILLIAM RDirector 2015-01-05Sell2,200$15.29.34view

Press Releases about SGMO :

    Quarterly/Annual Reports about SGMO:

    News about SGMO:

    Articles On GuruFocus.com
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 03 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 05 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 06 2009 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 03 2009 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2009 
    Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results Feb 04 2009 

    More From Other Websites
    Sangamo BioSciences Presents New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic® Designed... Feb 26 2015
    7:02 am Sangamo Biosci at CROI 2015 presents new clinical data from ZFP Therapeutic trial Feb 26 2015
    Sangamo BioSciences Presents New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic® Designed... Feb 26 2015
    Sangamo BioSciences Announces Presentation At The Cowen And Company 35th Annual Health Care... Feb 25 2015
    SANGAMO BIOSCIENCES INC Files SEC form 10-K, Annual Report Feb 25 2015
    Sangamo BioSciences Announces Presentation At The Cowen And Company 35th Annual Health Care... Feb 25 2015
    Sangamo BioSciences Presents Data At 11th Annual WorldSymposium™ Meeting Supporting In Vivo... Feb 12 2015
    Sangamo reports 4Q loss Feb 10 2015
    Sangamo reports 4Q loss Feb 10 2015
    Sangamo BioSciences Inc Earnings Call scheduled for 5:00 pm ET today Feb 10 2015
    SANGAMO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 10 2015
    Sangamo BioSciences Reports Fourth Quarter and Full Year 2014 Financial Results Feb 10 2015
    Q4 2014 Sangamo BioSciences Inc Earnings Release - After Market Close Feb 10 2015
    Will Sangamo (SGMO) Disappoint This Earnings Season? - Analyst Blog Feb 09 2015
    Sangamo BioSciences Announces Presentation At The 2015 Leerink Global Healthcare Conference Feb 05 2015
    Sangamo BioSciences Announces Presentation At The 2015 Leerink Global Healthcare Conference Feb 05 2015
    Sangamo BioSciences Announces FDA Acceptance of IND to Initiate Clinical Trial of its Novel ZFP... Feb 04 2015
    Sangamo BioSciences Announces Fourth Quarter and Full Year 2014 Conference Call and Webcast Feb 03 2015
    Sangamo BioSciences To Highlight 2015 Catalysts And Advancement Of ZFP Therapeutic Programs At The... Jan 12 2015
    Sangamo BioSciences To Highlight 2015 Catalysts And Advancement Of ZFP Therapeutic Programs At The... Jan 12 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK